His-tagged yuzA is supplied for structural or functional studies.
Feature | Details | Source |
---|---|---|
Purity | >80% (SDS-PAGE validated) | |
Endotoxin Level | <1.0 EU/µg (LAL method) | |
Form | Liquid or lyophilized powder | |
Lead Time | 5–9 weeks (custom production) |
yuzA belongs to a class of uncharacterized membrane proteins in B. subtilis, many of which remain understudied despite their potential roles in lipid synthesis, cell wall regulation, or stress response. While systematic studies on essential genes in B. subtilis have identified critical proteins (e.g., YkqC for ribosomal function) , yuzA’s function has not been experimentally validated.
Membrane Protein Families: yuzA shares structural similarities with transmembrane proteins involved in substrate transport or signaling .
Recombinant Utility: Recombinant B. subtilis strains expressing heterologous proteins (e.g., PEDV spike protein) have demonstrated utility in vaccine development , suggesting yuzA could serve as a scaffold for engineering.
Functional Prioritization: Unlike essential genes such as ydiB or yloQ, yuzA is not required for viability in B. subtilis, implying a non-critical but specialized role .
KEGG: bsu:BSU31380
STRING: 224308.Bsubs1_010100017056
What is the basic structural information available for the yuzA protein?
The yuzA protein is a small membrane protein from Bacillus subtilis (strain 168) with a molecular weight of approximately 8,466 Da . The full amino acid sequence consists of 78 amino acids: "MSTIQRICLVLTIIGAINWGLIGFFQFDLVAAIFGGQGSALSRIIYGLVGIAGLINLGLLFKPNEERSREEAANPEMR" . Structural prediction suggests it contains multiple transmembrane domains characteristic of integral membrane proteins, with hydrophobic regions that likely span the bacterial cell membrane . Three-dimensional structural information can be accessed through ModBase using the UniProt accession number O32087, which provides computational predictions of the protein's folding pattern .
What expression systems are commonly used for producing recombinant yuzA protein?
Recombinant yuzA protein can be produced in several expression systems including E. coli, yeast, baculovirus, or mammalian cell systems . The choice of expression system depends on the specific experimental requirements, including the need for post-translational modifications, protein folding considerations, and downstream applications. E. coli systems are often preferred for their simplicity and high yield, particularly for membrane proteins that don't require extensive post-translational modifications . The recombinant versions typically include tags (N-terminal and potentially C-terminal) to facilitate purification and detection in experimental settings .
What is the current annotation status of yuzA in genomic databases?
The yuzA protein is currently classified as an "Uncharacterized membrane protein" in UniProt (primary accession O32087) and as a "hypothetical protein BSU31380" in NCBI databases (GenBank nucleotide accession NC_000964.3, protein accession NP_391016.1) . This classification indicates that while the gene has been identified through genomic sequencing of Bacillus subtilis strain 168, its precise biological function remains undetermined . In the BioCyc Collection of Pathway/Genome Databases, it is referenced as iBSUB:BSU31380-MONOMER, suggesting its inclusion in metabolic pathway analysis despite its uncharacterized status .
What are the optimal storage conditions for recombinant yuzA protein?
For optimal preservation of recombinant yuzA protein activity and stability, store the protein at -20°C for regular storage or at -80°C for long-term storage . Working aliquots can be maintained at 4°C for up to one week to minimize freeze-thaw cycles . The protein is typically supplied in a stabilizing buffer containing glycerol (often 50%) and Tris-based components optimized for the specific protein preparation . Repeated freezing and thawing should be avoided as this can lead to protein denaturation and loss of activity . For proteins received in lyophilized form, reconstitution should be performed according to the manufacturer's protocol using the appropriate buffer system .
What purification approaches yield the highest purity of recombinant yuzA?
High-purity recombinant yuzA protein (≥85% as determined by SDS-PAGE) is typically achieved through multi-step purification protocols . The process generally begins with affinity chromatography utilizing the protein's fusion tags (N-terminal or C-terminal tags commonly employed) . This is often followed by size exclusion chromatography to remove aggregates and separate the protein of interest based on molecular weight . For membrane proteins like yuzA, detergent-based extraction from expression system membranes is a critical initial step that significantly impacts downstream purity . The precise detergent selection and concentration require optimization for efficient solubilization while maintaining protein structure and function.
What experimental approaches are most effective for determining the membrane topology of yuzA?
Determining the membrane topology of yuzA requires a multi-faceted approach combining computational prediction with experimental validation. Computational analyses using hydropathy plots and transmembrane prediction algorithms provide initial models of membrane-spanning regions . These predictions can be experimentally validated using techniques such as cysteine scanning mutagenesis coupled with accessibility assays, where strategically placed cysteine residues are tested for reactivity with membrane-impermeable reagents. Protease protection assays, where regions accessible to proteolytic digestion indicate exposure to either the cytoplasmic or extracellular environment, provide complementary data. For higher resolution structural information, techniques such as cryo-electron microscopy or X-ray crystallography may be employed, though these present significant technical challenges for membrane proteins.
How can researchers effectively design experiments to elucidate the function of an uncharacterized protein like yuzA?
Elucidating the function of uncharacterized proteins like yuzA requires a systematic approach combining genetic, biochemical, and physiological methods. Gene knockout or depletion studies provide initial insights into phenotypic consequences, revealing potential physiological roles3. Complementation experiments, where the wild-type gene is reintroduced into knockout strains, confirm phenotype specificity. Protein-protein interaction studies using techniques such as bacterial two-hybrid systems, co-immunoprecipitation, or crosslinking approaches can identify functional partners3. Comparative genomics analysis identifying conserved domains or sequence similarities with characterized proteins may suggest functional roles. Additionally, heterologous expression in model systems followed by functional assays targeting predicted activities provides direct biochemical evidence. Throughout this process, researchers must systematically test hypotheses while remaining unbiased toward unexpected results3.
What are the critical controls needed when working with recombinant yuzA in membrane protein studies?
When designing experiments involving recombinant yuzA, several critical controls must be incorporated to ensure result validity and interpretability. Negative controls should include empty vector-transfected cells or purification from expression systems lacking the yuzA construct3. Positive controls using well-characterized membrane proteins of similar size or topology validate experimental conditions and protocols. For functional studies, a truncated or point-mutated version of yuzA (targeting predicted functional domains) provides critical comparative data3. When analyzing membrane integration, controls using known membrane and soluble proteins help confirm fractionation efficiency. For interaction studies, controls testing for non-specific binding are essential, particularly given the hydrophobic nature of membrane proteins3. The experimental design should also account for potential artifacts introduced by fusion tags, with tag-only and tag-cleaved controls where feasible.
How should researchers address potential tag interference in functional studies of recombinant yuzA?
Addressing tag interference in yuzA functional studies requires systematic validation approaches. Researchers should compare different tag positions (N-terminal versus C-terminal) to determine position-dependent effects on protein function and localization . Employing cleavable tags with precision proteases allows comparative studies of tagged versus untagged protein activity . Size considerations are important; smaller tags like His6 or FLAG generally cause less interference than larger tags like GFP or MBP . Control experiments comparing tagged yuzA with native protein (where possible) provide direct evidence of tag effects. Structural modeling to predict potential tag interference with transmembrane domains or functional sites can guide tag design . For comprehensive validation, researchers should perform parallel experiments using different tag systems and correlate results across multiple experimental approaches to distinguish authentic protein behavior from tag artifacts.
How can researchers distinguish genuine yuzA-specific effects from experimental artifacts in functional studies?
Distinguishing genuine yuzA-specific effects from artifacts requires rigorous experimental design and analysis. Researchers should implement dose-response relationships, where effects that scale with yuzA concentration are more likely genuine than artifacts showing binary or random patterns3. Employing multiple independent methods to measure the same parameter provides convergent validation. Genetic approaches using site-directed mutagenesis targeting specific residues should produce graded effects correlating with the severity of the mutation3. Temporal controls establishing the sequence of events following yuzA introduction or activation help establish causality. Statistical analysis must account for biological and technical replication, with appropriate significance testing3. Complementation experiments, where the wild-type protein rescues effects of deletion or mutation, provide strong evidence for specificity. Finally, researchers should compare results across different experimental systems and conditions to identify consistent patterns indicating genuine biological functions versus system-specific artifacts.
What statistical approaches are most appropriate for analyzing membrane protein interaction data involving yuzA?
Analyzing membrane protein interaction data for yuzA requires specialized statistical approaches addressing unique challenges of membrane protein biochemistry. For co-immunoprecipitation or pull-down assays, quantitative western blot analysis should include normalization to input protein levels with statistical comparison to non-specific binding controls3. For techniques like FRET or BiFC measuring direct interactions, statistical analysis should account for background fluorescence and protein expression variability through appropriate normalization3. When using crosslinking approaches, statistical modeling should distinguish specific from random proximity events based on crosslink frequency distributions. Protein correlation profiling across fractionation gradients requires multivariate statistical approaches like principal component analysis to identify co-migrating proteins3. For all interaction data, false discovery rate control is essential given the multiple testing inherent in proteome-wide interaction screens. Bayesian network analysis can integrate diverse interaction data types to improve confidence in specific interactions while accounting for the technical limitations of each method.
What are the key considerations for optimizing ELISA protocols using recombinant yuzA?
Optimizing ELISA protocols for recombinant yuzA requires systematic parameter adjustment addressing both general ELISA principles and specific challenges of membrane proteins. Blocking optimization is critical, with proteins like BSA, casein, or commercial blocking formulations systematically compared for signal-to-noise ratio improvement . Detergent selection and concentration in washing and sample buffers must balance membrane protein solubilization with assay compatibility . Antibody concentration and incubation conditions require titration experiments to determine optimal dilutions and times that maximize specific signals while minimizing background . For direct ELISAs, coating conditions (buffer composition, pH, and protein concentration) significantly impact protein adherence to plates while maintaining native conformation . Temperature control during incubation steps affects both reaction kinetics and protein stability. Calibration curves using purified recombinant yuzA at known concentrations ensure quantitative accuracy and determine the linear detection range . Finally, optimization should include assessment of intra- and inter-assay variability to establish reproducibility metrics.
How can researchers effectively solubilize yuzA while maintaining its native conformation?
Effective solubilization of yuzA while preserving its native conformation requires careful selection and optimization of detergent systems. Initial screening should include diverse detergent classes including mild non-ionic detergents (DDM, LMNG), zwitterionic detergents (CHAPS, Fos-choline), and newer amphipathic polymers like SMALPs or nanodiscs . Detergent concentration optimization is critical, starting at 2-10× critical micelle concentration (CMC) with systematic titration to identify minimal effective concentrations . Temperature control during solubilization affects efficiency and protein stability, with conditions typically ranging from 4°C to room temperature depending on protein stability . The buffer composition should be optimized for pH, ionic strength, and presence of stabilizing agents like glycerol or specific lipids that may be required for native conformation . Validation of native conformation can be assessed through functional assays, circular dichroism spectroscopy, or limited proteolysis patterns. For particularly challenging cases, systematic comparison of detergent extraction versus detergent-free approaches like SMALPs may be necessary to identify conditions that best preserve native protein structure and interactions.
What strategies can address poor expression yields of recombinant yuzA?
Addressing poor expression yields of recombinant yuzA requires a systematic optimization approach targeting multiple expression parameters. Codon optimization for the expression host can significantly improve translation efficiency, particularly for heterologous expression of bacterial proteins . Expression vector selection should evaluate different promoter strengths and inducible versus constitutive expression systems . For toxic membrane proteins, tightly controlled inducible systems with optimized induction parameters (inducer concentration, temperature, timing) often improve yields. Fusion partners like MBP or SUMO can enhance folding and stability . Host strain selection should consider specialized strains designed for membrane protein expression with modified secretion pathways or chaperone systems . Growth media composition and culture conditions, including temperature reduction during induction (often to 16-20°C), aeration rates, and culture density at induction, significantly impact membrane protein yields. For cases of suspected protein toxicity, screening C-terminal versus N-terminal fusion constructs or periplasmic versus cytoplasmic targeting can identify optimal expression strategies.
How should researchers troubleshoot non-specific binding issues in yuzA interaction studies?
Non-specific binding in yuzA interaction studies requires systematic troubleshooting addressing both general and membrane protein-specific factors. Increasing stringency in washing steps through adjusted detergent types/concentrations and salt concentrations can reduce non-specific hydrophobic and ionic interactions, respectively3. Pre-clearing samples with the matrix alone (without capture antibody/ligand) removes components with affinity for the matrix3. For co-immunoprecipitation, cross-adsorbed and affinity-purified antibodies minimize non-specific capture. Competitive blocking using excess non-biotinylated protein can confirm binding specificity in surface plasmon resonance or pull-down experiments3. Detergent optimization is particularly critical for membrane proteins like yuzA, as insufficient detergent leads to non-specific hydrophobic aggregation while excess detergent may disrupt genuine interactions3. Sequential extraction protocols using increasing detergent strengths can help differentiate strong specific interactions from weaker non-specific associations. Control experiments using non-relevant membrane proteins of similar hydrophobicity provide critical comparative data to distinguish true interactors from methodological artifacts.
Condition | Recommendation | Duration | Notes |
---|---|---|---|
Long-term Storage | -20°C to -80°C | Months to years | Avoid repeated freeze-thaw cycles |
Working Storage | 4°C | Up to one week | For active experiments |
Storage Buffer | Tris-based buffer with 50% glycerol | - | Optimized for protein stability |
Lyophilized Form | -20°C | Extended periods | Requires reconstitution before use |
Reconstituted Form | As recommended for specific application | - | Consider aliquoting to avoid freeze-thaw |
Research Phase | Approach | Controls | Analytical Methods |
---|---|---|---|
Expression Validation | Western blot, SDS-PAGE | Empty vector, known B. subtilis protein | Densitometry, mass spectrometry |
Membrane Integration | Fractionation, localization studies | Known membrane and soluble proteins | Fluorescence microscopy, western blot of fractions |
Functional Screening | Gene knockout, phenotypic analysis | Wild-type strain, complementation | Growth curves, stress response, metabolic assays |
Interaction Studies | Co-IP, crosslinking, bacterial two-hybrid | Tag-only controls, random protein controls | Mass spectrometry, western blot, fluorescence |
Structural Analysis | Computational prediction, CD spectroscopy | Similar-sized membrane proteins | Hydropathy plots, secondary structure prediction |